Provided by Tiger Trade Technology Pte. Ltd.

Vivos Therapeutics

1.19
+0.05004.39%
Volume:255.23K
Turnover:321.54K
Market Cap:12.46M
PE:-0.62
High:1.36
Open:1.13
Low:1.10
Close:1.14
52wk High:7.95
52wk Low:1.09
Shares:10.47M
Float Shares:8.39M
Volume Ratio:2.55
T/O Rate:3.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9054
EPS(LYR):-2.2184
ROE:-335.45%
ROA:-49.76%
PB:4.92
PE(LYR):-0.54

Loading ...

Apr 17, 2025

Major Issues Report

Form 8-K - Current report
Mar 31, 2025

Major Issues Report

Form 8-K - Current report
Mar 31, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2025

Major Issues Report

Form 8-K - Current report
Jan 29, 2025

Correspondence

Form CORRESP - Correspondence
Jan 29, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 22, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Dec 23, 2024

Major Issues Report

Form 8-K - Current report
Nov 27, 2024

Major Issues Report

Form 8-K - Current report
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 15, 2024

Major Issues Report

Form 8-K - Current report
Nov 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Sep 24, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Sep 20, 2024

Major Issues Report

Form 8-K - Current report
Sep 18, 2024

Major Issues Report

Form 8-K - Current report
Sep 18, 2024

Major Issues Report

Form 8-K - Current report
Sep 12, 2024

Major Issues Report

Form 8-K - Current report
Aug 15, 2024

Major Issues Report

Form 8-K - Current report
Aug 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]